Single nucleotide polymorphisms in TP53 but not KRAS or MDM2 are predictive of clinical outcome in multiple myeloma treated with high-dose melphalan and autologous stem cell support. Issue 6 (2nd June 2016)

Record Type:: Journal Article
Title:: Single nucleotide polymorphisms in TP53 but not KRAS or MDM2 are predictive of clinical outcome in multiple myeloma treated with high-dose melphalan and autologous stem cell support. Issue 6 (2nd June 2016)
Main Title:: Single nucleotide polymorphisms in TP53 but not KRAS or MDM2 are predictive of clinical outcome in multiple myeloma treated with high-dose melphalan and autologous stem cell support
Authors:: Gebauer, Niklas
Biersack, Harald
Czerwinska, Ann-Cathrin
Schemme, Janina
Hardel, Tim Tristan
Bernard, Veronica
Rades, Dirk
Lehnert, Hendrik
Luley, Kim Barbara
Thorns, Christoph
Abstract:
Is Part Of:: Leukemia & lymphoma. Volume 57:Issue 6(2016:Jun.)
Journal:: Leukemia & lymphoma
Issue:: Volume 57:Issue 6(2016:Jun.)
Issue Display:: Volume 57, Issue 6 (2016)
Year:: 2016
Volume:: 57
Issue:: 6
Issue Sort Value:: 2016-0057-0006-0000
Page Start:: 1482
Page End:: 1486
Publication Date:: 2016-06-02
Subjects:: Leukemia -- Periodicals
Lymphomas -- Periodicals
616.99419
Journal URLs:: http://informahealthcare.com ↗
DOI:: 10.3109/10428194.2015.1099648 ↗
Languages:: English
ISSNs:: 1042-8194
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 5185.251500
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store
Ingest File:: 2727.xml